Inclusive of all taxes
Montelukast & Doxofylline Tablets are a specialized pharmaceutical formulation developed for the efficacious treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). This combination tablet integrates Montelukast, a leukotriene receptor antagonist that reduces inflammation and bronchoconstriction, with Doxofylline, a bronchodilator that enhances airway relaxation and eases breathing difficulties. Manufactured by IndiGlobal Exports under stringent WHO-GMP compliance, these tablets are designed to deliver consistent therapeutic benefits with precise dosing to patients in both hospital and retail pharmacy environments. Packaged in export-grade blister or strip packs, these tablets comply with international healthcare regulations, making them suitable for global pharmaceutical markets seeking quality-assured respiratory medications. The product emphasizes reliability, safety, and adherence to pharmacopoeial standards such as IP and USP for maximum patient outcomes in respiratory disease management.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Montelukast Sodium and Doxofylline |
| Therapeutic Use | Management of respiratory conditions including asthma and COPD |
| Dosage Form | Tablet |
| Packaging | Export-grade blister or strip packs |
| Manufacturing Compliance | WHO-GMP certified facilities |
| Quality Standards | Complies with pharmacopoeial standards (IP/USP) |
| Shelf Life | As per regulatory standards |
| Manufacturer | IndiGlobal Exports |
| Market Suitability | Suitable for international regulated and semi-regulated pharmaceutical markets |
| Attributes | Description |
|---|---|
| Category | Respiratory |
| Formulation | Tablet |
| Active Pharmacological Agents | Montelukast (anti-leukotriene), Doxofylline (bronchodilator) |
| Packaging Type | Blister or strip packs designed for export |
| Compliance | WHO-GMP, IP and USP standards |
| Intended Use | Clinical and ongoing respiratory condition management |
| Storage Requirements | Store in a cool, dry place away from direct sunlight |
| Batch Consistency | Stringent quality control to ensure uniform dosage and efficacy |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
These tablets are manufactured in WHO-GMP certified facilities with adherence to IP and USP pharmacopoeial standards, and packaged in export-grade blister or strip packs that meet global regulatory requirements.
Montelukast reduces airway inflammation and bronchoconstriction by blocking leukotriene receptors, while Doxofylline serves as a bronchodilator that relaxes airway muscles, together providing complementary effects for improved respiratory relief.
Yes, the combination formulation is indicated for management of various respiratory conditions including asthma and COPD, offering therapeutic benefit for both types of patients.
Montelukast & Doxofylline tablets are supplied in export-grade blister or strip packs designed for bulk export and institutional supply, ensuring product stability during transit.
The manufacturer enforces stringent batch testing and quality control protocols to maintain uniform dosage accuracy, safety, and therapeutic efficacy across production runs.
Brand: indiglobal exports
Country Of Origin: India
Montelukast & Doxofylline Tablets is a pharmaceutical product indicated for respiratory treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Montelukast & Doxofylline Tablets is developed for the effective management of respiratory conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with respiratory indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
